Clinical Trials on Bipolar I Disorder, Most Recent Episode Depressed in Poland

Total 37 results

Sumitomo Pharma America, Inc.

Terminated

A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.

Depressive Episodes, Bipolar I Depression

United States, Bulgaria, Japan, Romania, Canada, Slovakia
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder

Bipolar I Disorder | Manic Episode

Serbia, United States, Bulgaria, Poland
Sumitomo Pharma America, Inc.

Terminated

A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).

Depressive Episodes, Bipolar I Depression

United States, Bulgaria, Japan
Butler Hospital

Terminated

NeoSync TMS Treatment for Bipolar I Depression (NESTTBID)

Mood Disorders | Bipolar Disorder | Bipolar Depression | Major Depressive Episode

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features. (ATTAIN 267)

Adolescent Schizophrenia | Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features

India, United States, Bulgaria, Croatia, Hungary, Malaysia, Philippines, Poland, Romania, Russian Federation, Serbia, Taiwan, Ukraine
The Medical Research Network
Pfizer; Liebowitz, Michael R., M.D.

Completed

Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression

Major Depressive Episode | Bipolar II Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Bipolar I Disorder

United States, Taiwan, Romania, Korea, Republic of, Japan, Poland, Canada
diaMentis Inc.

Active, not recruiting

ERG Components in Schizophrenia and Bipolar Disorder Type I

Schizophrenia | Bipolar I Disorder

United States, Australia, Canada
Sunovion

Completed

A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression

Depressive Episode | Bipolar 1 Depression

Japan, Serbia, United States, Poland, Russian Federation, Bulgaria, Slovakia, Ukraine
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Bipolar I Disorder

United States, Argentina
Sunovion

Completed

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 (PERSISTExt)

Bipolar I Disorder

United States, Poland, Bulgaria, Japan, Slovakia, Hungary, Russian Federation, Czech Republic, Argentina, Chile, France, Serbia
AbbVie

Recruiting

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Depression | Bipolar I Disorder

United States, Puerto Rico, Russian Federation
Sunovion

Completed

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex (PERSIST)

Bipolar I Disorder

United States, Croatia, Hungary, Poland, Serbia, Argentina, Japan, France, Slovakia, Australia, Russian Federation, Bulgaria, Chile, Czech Republic
Novartis Pharmaceuticals

Completed

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Bipolar Disorder

United States
Novartis

Completed

Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder

Bipolar Disorder

Austria, Canada, Czech Republic, Germany, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela, United States, Colombia, Guatemala
Sunovion

Completed

Lurasidone Pediatric Bipolar Study (Illuminate)

Bipolar I Depression

United States, Korea, Republic of, Bulgaria, Poland, Mexico, Puerto Rico, Colombia, Hungary, France, Philippines, Ukraine
Novartis Pharmaceuticals

Completed

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Bipolar Disorder

United States, Austria, Canada, Colombia, Czech Republic, Germany, Guatemala, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela
Cephalon

Completed

Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Bipolar I Depression

United States, Bulgaria, Hungary, Romania
Eli Lilly and Company

Completed

Study in Adolescents With Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar I Disorder

Puerto Rico, Russian Federation, United States, Poland
Alkermes, Inc.

Enrolling by invitation

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

Schizophrenia | Bipolar I Disorder

United States, Argentina, Brazil, Colombia, Mexico
BioXcel Therapeutics Inc
Worldwide Clinical Trials

Active, not recruiting

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

Schizophrenia | Schizoaffective Disorder | Bipolar I Disorder | Bipolar II Disorder | Agitation,Psychomotor | Schizophreniform Disorders

United States
Repligen Corporation

Completed

A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression

Bipolar I Depression

United States
Alkermes, Inc.

Completed

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

Schizophrenia | Schizophreniform Disorder | Bipolar I Disorder

United States, Bulgaria, Russian Federation, Ukraine, Austria, Ireland, Israel, Italy, Korea, Republic of, Poland, United Kingdom, Serbia, Puerto Rico
AstraZeneca

Completed

Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder (ANCHOR 150)

Schizophrenia | Bipolar I Disorder

United States, Russian Federation, Philippines, Malaysia, South Africa, Poland, Serbia, Ukraine, India
Vanda Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Bipolar I Disorder

United States, Bulgaria, Poland
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Bipolar I Disorder

United States, Hungary, Poland, Spain
AstraZeneca

Completed

Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Bipolar I Disorder

United States, Sweden, Bulgaria, France, Italy, Poland, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Czech Republic, Hungary, Finland, Norway, Australia, Belgium
AbbVie

Recruiting

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

Schizophrenia | Bipolar I Disorder | Autism Spectrum Disorder (ASD)

United States, Puerto Rico
AstraZeneca

Completed

Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder

Alcohol Dependence | Bipolar I Disorder

United States
Alkermes, Inc.

Completed

Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder

Schizophrenia | Bipolar I Disorder | Schizophreniform Disorders

United States, Korea, Republic of, Russian Federation, Ukraine, Austria, Germany, Ireland, Israel, Italy, Poland, Spain, United Kingdom
Alkermes, Inc.

Recruiting

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Schizophrenia | Bipolar I Disorder

United States, Argentina, Mexico, Brazil, Colombia
AbbVie

Completed

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Depression | Mania | Bipolar I Disorder

United States, Bulgaria, Korea, Republic of, Malaysia, Poland, Puerto Rico, Russian Federation, Serbia, Taiwan, Thailand, Ukraine
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

Bipolar I Disorder | Acute Mania

United States, Serbia, Bulgaria, Croatia, Poland, Ukraine
Polish Lymphoma Research Group
AstraZeneca

Active, not recruiting

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT) (ACALLO)

Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Adverse Event | Chronic Graft-versus-host-disease | Response Rate

Poland
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Recruiting

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Acute Lymphoblastic Leukemia | Acute Leukemia | Blastic Plasmacytoid Dendritic Cell Neoplasm | Acute Leukemia of Ambiguous Lineage | Acute Undifferentiated Leukemia | Acute Biphenotypic Leukemia | Myelodysplastic Syndrome With Excess Blasts-1 | Mixed Phenotype Acute Leukemia | Blasts Under 5 Percent... and other conditions

United States
OMNI Medical Services, LLC
OMNI Medical Services Inc

Recruiting

Outcomes Mandate National Integration With Cannabis as Medicine (OMNI-Can)

Depression | COVID-19 | Epilepsy | Multiple Sclerosis | Glaucoma | Cancer | Covid19 | Chronic Pain | Parkinson Disease | Inflammatory Bowel Diseases | Hepatitis C | Insomnia | HIV/AIDS | Amyotrophic Lateral Sclerosis | Fibromyalgia | Anxiety | Bipolar Disorder | Seizures | Crohn Disease | Traumatic Brain Injury | Ulcerative Colitis | Sickle... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Clear Cell Renal Cell Carcinoma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent... and other conditions

United States, Germany, Italy

Clinical Trials on Bipolar I Disorder, Most Recent Episode Depressed in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations